Skip to search formSkip to main contentSkip to account menu

Wy 41770

Known as: Wy-41,770, Wy-41770 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Utilizing an adjuvant arthritis model in rats, we examined humoral immunity to collagen and inflammation in animals with active… 
2005
2005
Wy-41,770 [(5H-dibenzo[a,d]cyclohepten-5-ylidene)acetic acid], a novel acrylic acid, was compared to indomethacin and aspirin in… 
1988
1988
The intestinal ulcerogenic activity of the weak prostaglandin synthesis inhibitor drug Wy-41,770 [5H-dibenzo(a,d)-cyclohepten-5… 
1986
1986
The immunomodulatory effects of Wy-41,770 (5H-dibenzo[a,d]cyclohepten-5-ylidene) acetic acid, were compared to levamisole and…